Welch Allyn has announced that several of its vital signs devices, monitors and electrocardiography units are to offer connectivity with Epic's Electronic Medical Records (EMR) system. Read More
Novo Nordisk has announced the completion of Paradigm 2, a new study that has underlined the benefits of the investigational haemophilia B therapy N9-GP. Read More
Biogen Idec has announced that its interim chief scientific officer (CSO) Dr Spyros Artavanis-Tsakonas is to continue in the role on a permanent basis. Read More
MSD Animal Health has announced that its new vaccine product Bovilis SBV has been granted a provisional marketing authorisation by the UK's Veterinary Medicines Directorate (VMD). Read More
Ranbaxy has highlighted the efforts it has been making to improve its business and quality assurance standards in order to improve global confidence in the company. Read More
Scientists in the US have shown that omega-3 fatty acid capsules could help to deliver lower risks of type 2 diabetes and coronary heart disease. Read More
BD has highlighted its strategic priorities and performance on environmental and community projects in its annual sustainability report for 2012. Read More
The British Medical Association (BMA) has called on the government to cooperate with GPs in order to tackle the current pressures on frontline care. Read More
Fisher and Paykel has announced its financial results for the business year ending on March 31st 2013, during which it achieved a record performance. Read More
Covidien has announced the results from a clinical trial showing the benefits its Barrx RF Ablation System can provide in the treatment of Barrett's oesophagus. Read More
Adelphi Communications has announced a major new brand update that will allow it to better serve the needs of pharmaceutical, diagnostics and device industry clients. Read More
Gilead Sciences has announced that the European Medicines Agency has accepted its new chronic hepatitis C virus (HCV) therapy sofosbuvir for review. Read More
Bayer HealthCare has announced the appointment of Johannes Schubmehl as its new chief information officer (CIO), effective as of the beginning of this month. Read More
Boehringer Ingelheim has honoured the winner of the Healthcare Innovation World Cup, an international diabetes innovation challenge it helped to fund. Read More
AbbVie has announced the launch of a phase III trial of the investigational compound atrasentan to assess its impact on renal outcomes in patients with diabetic nephropathy. Read More
Actavis has entered into a definitive agreement to acquire fellow healthcare company Warner Chilcott in a stock-for-stock transaction valued at around $8.5 billion (5.64 billion pounds). Read More
